Dennis R. Delaney’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,632
Closed -$247K 54
2019
Q1
$247K Buy
+2,632
New +$230K 0.33% 47
2018
Q4
Sell
-6,410
Closed -$573K 55
2018
Q3
$573K Buy
6,410
+233
+4% +$20.6K 0.75% 37
2018
Q2
$491K Buy
6,177
+330
+6% +$27.4K 0.71% 37
2018
Q1
$522K Buy
5,847
+2,632
+82% +$253K 0.73% 38
2017
Q4
$336K Buy
+3,215
New +$363K 0.45% 44

Other funds holding CELG

Dennis R. Delaney's CELG Position: Q2 2019 in Review

Dennis R. Delaney sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 2,632 shares — an estimated $247K sold.

Dennis R. Delaney first reported a position in CELG in Q4 2017 and held it in 5 quarters. The position peaked at $573K in Q3 2018. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Dennis R. Delaney reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Dennis R. Delaney sold 2,632 Celgene Corp shares in Q2 2019, an estimated $247K.
  • Dennis R. Delaney first reported a position in Celgene Corp in Q4 2017 and held it in 5 quarters.
  • Dennis R. Delaney's Celgene Corp position peaked at $573K in Q3 2018.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Dennis R. Delaney's 13F filing for Q2 2019, filed 24 Jul 2019.